SHJBF (Shanghai Junshi Biosciences Co) Total Equity: $862.3 Mil (As of Dec. 2025)


SHJBF Shanghai Junshi Biosciences Co Ltd SHJBF
66 GF Score
Price $3.35
GF Value $5.63
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Shanghai Junshi Biosciences Co Total Equity?

Shanghai Junshi Biosciences Co SHJBF +11.67% 66 Total Equity is $862.3 Mil as of Dec. 2025. GuruFocus rates SHJBF with a GF Score™ of 66/100 and a GF Value™ of $5.63 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Shanghai Junshi Biosciences Co's total equity for the quarter that ended in Dec. 2025 was $862.3 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Shanghai Junshi Biosciences Co Total Equity Historical Data

* Premium members only.

The historical data trend for Shanghai Junshi Biosciences Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Junshi Biosciences Co Total Equity Chart

Shanghai Junshi Biosciences Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,308.18 1,404.86 1,028.01 817.26 862.29

Shanghai Junshi Biosciences Co Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,028.01 912.98 817.26 892.64 862.29
SHJBF
66GF Score
Shanghai Junshi Biosciences Co Ltd SHJBF
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Junshi Biosciences Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Shanghai Junshi Biosciences Co's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=1760.419-898.134
=862.3

Shanghai Junshi Biosciences Co's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=1760.419-898.134
=862.3

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $862.3 Mil mean?
Shanghai Junshi Biosciences Co (SHJBF) has a Total Equity of $862.3 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Shanghai Junshi Biosciences Co and its competitors.
Is Shanghai Junshi Biosciences Co's Total Equity too high?
Shanghai Junshi Biosciences Co's current Total Equity is $862.3 Mil. Overall, Shanghai Junshi Biosciences Co has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Junshi Biosciences Co's Total Equity compare to VRTX and REGN?
Shanghai Junshi Biosciences Co's Total Equity of $862.3 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Shanghai Junshi Biosciences Co and its competitors. Shanghai Junshi Biosciences Co's current Total Equity is $862.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Junshi Biosciences Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Junshi Biosciences Co (SHJBF) is currently considered Significantly Undervalued. The stock's GF Value™ is $5.63, compared to a current price of $3.35 — trading 40.5% below its estimated fair value. The current Total Equity is $862.3 Mil. Shanghai Junshi Biosciences Co's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Shanghai Junshi Biosciences Co (SHJBF), the current Total Equity is $862.3 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Junshi Biosciences Co (SHJBF) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Junshi Biosciences Co stock appears to be undervalued. The current stock price of $3.35 is trading 40.5% below its estimated GF Value™ of $5.63. GuruFocus considers Shanghai Junshi Biosciences Co to be Significantly Undervalued.

Key valuation signals for SHJBF:

  • Total Equity: $862.3 Mil
  • GF Value™: $5.63 vs. price of $3.35 (40.5% below fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the SHJBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Junshi Biosciences Co Business Description

Other Exchanges 01877:Hong Kong688180:China
Address No. 987 Cai Lun Road, Level 4, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN
Shanghai Junshi Biosciences Co Ltd is mainly involved in the discovery, development, and commercialisation of therapeutic drugs. It focuses on the development and commercialization of several kinds of drugs, ranging from monoclonal antibodies to various drug modalities, including small molecules, ADCs, bi-specific or multi-specific antibodies, fusion proteins, nucleic acid drugs, and vaccines, as well as the exploration of next-generation therapies, including those for cancer and autoimmune diseases. The Group's portfolio includes commercialized drugs such as Tuoyi, Junmaikang, Mindewei, and Junshida, as well as products in clinical studies or in the marketing application stage. Geographically, it derives maximum revenue from Mainland China, and the rest from USA, India, and other markets.
66GF Score

Get the complete analysis for SHJBF

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.35
Price
$5.63
GF Value